吉玛基因是由海归学者团队共同创办的高科技生物技术公司，目前约有员工300人，场地面积13,000m²。公司长期专注于RNA领域，拥有一体化的RNA技术整合开发平台，可以完成从RNA单体生产、oligo设计和合成、针对靶基因的高通量筛选、体内/体外评价等临床前研究。核酸原料药GMP生产车间和生产基地也能为未来的临床研究、药品注册和商业化生产提供支持。

公司的伴随诊断包括荧光定量、质谱、RNAFISH三个技术平台，同时建成了1,000m²的三类诊断试剂GMP生产车间。

动物平台有转基因动物、CDX、PDX动物模型，还有配备有1,340m²的SPF级的动物房。

吉玛公司希望利用现有平台为大型药企尽快进入RNA药物领域提供平台和支持。

Genepharma  is a high-tech biotechnology company founded by overseas scholars. At present, it has about 300 employees and a site area of 13,000m².

The company has long been dedicated to the RNA field, boasting an integrated RNA technology development platform capable of handling preclinical studies from single RNA production, oligonucleotide design and synthesis, high-throughput screening for target genes, to in vivo/in vitro evaluation. The GMP manufacturing facilities and production bases for nucleic acid APIs also support future clinical research, drug registration, and commercial production.

The companys companion diagnostics include three technology platforms: fluorescence quantitative, mass spectrometry and RNA FISH. At the same time, a GMP production workshop of 1,000m² for class III diagnostic reagents has been built.

The animal platform has transgenic animals, CDX and PDX animal models, as well as an SPF level 1,340m² animal house.

Genepharma hopes to use the existing platform to provide a platform and support for large pharmaceutical companies to enter the RNA drug field as soon as possible.